-
Signature
-
/s/ Chad Porter, by power of attorney
-
Issuer symbol
-
BSTG
-
Transactions as of
-
26 Nov 2021
-
Transactions value $
-
$0
-
Form type
-
3
-
Filing time
-
30 Nov 2021, 17:10:48 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
BSTG |
Common Stock |
|
|
|
|
|
23,052 |
26 Nov 2021 |
Direct |
|
| holding |
BSTG |
Common Stock |
|
|
|
|
|
16,468 |
26 Nov 2021 |
2018 Biostage GRAT |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| holding |
BSTG |
Stock Option (right to buy) |
|
|
|
|
|
|
26 Nov 2021 |
Common Stock |
1,250 |
$33.8 |
Direct |
F1 |
| holding |
BSTG |
Stock Option (right to buy) |
|
|
|
|
|
|
26 Nov 2021 |
Common Stock |
1,250 |
$36.8 |
Direct |
F1 |
| holding |
BSTG |
Stock Option (right to buy) |
|
|
|
|
|
|
26 Nov 2021 |
Common Stock |
36,281 |
$85.8 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Interim Chief Executive Officer